Demystifying Dolutegravir based antiretroviral drug regimens

ZIMBABWE recently joined other nations to adopt the new HIV treatment regimens that contain Dolutegravir (DTG).  The complete transition process for Zimbabwe however, will not take less than 10 months to be fully implemented considering that the country has over a million people on first line HIV medicines. By Michael Gwarisa and Dr. Simbarashe Mabaya Countries  adopt normative guidance by the World Health Organization (WHO) which is based on rigorous review and analysis of scientific evidence. Based on this review WHO develops recommendations which make up the next guidelines. Countries…

Share
Read More

PEPFAR Launches 2019 HIV Media Awards

THE United States  President’s Emergency Plan for AIDS Relife (PEPFAR) on Friday launched the HIV/AIDS Media Awards competition as a way to recognise along with appreciating Zimbabwean journalists’ efforts in educating and informing Zimbabwe on the disease.  By Kudakwashe Pembere The awards cover photo, print, online and broadcast journalism. Entries should have been published or broadcast between October 2018 and October 2019.  Announcing the launch at PEPFAR’s 15 th anniversary in Zimbabwe,   PEPFAR Coordinator Mr Mark Troger said the awards were in their third year running.   “So tonight…

Share
Read More

HealthTimes Reporter Wins National HIV/AIDS Reporting Award

THE United States Embassy, through support from the US President’s Emergency Plan for AIDS Relief (PEPFAR) recognised four Zimbabwean Journalists for outstanding contribution to HIV and AIDS reporting in Zimbabwe. By Kudakwashe Pembere Speaking during the awards ceremony, Jennifer Savage, Charge d, Affairs at the United States Embassy said the awards are a symbol of continued U.S commitment to ensuring that Zimbabweans had access to information about support services available to those affected by HIV. “Your commitment to reporting on issues that affect your communities as well as solutions being…

Share
Read More